Walder Wyss advised Zeiss in the acquisition of the Zurich and Coswig (Germany) based lithography division of Beyond Gravity, a complex mechatronic assemblies supplier. The Coswig site will be integrated into Carl Zeiss SMT, while
Tags :Christoph Burckhardt
In a groundbreaking move, Boehringer Ingelheim has sealed the deal to acquire T3 Pharmaceuticals, a dynamic Swiss biotech company, for a staggering amount of up to 450 million CHF. This strategic move signals a major leap
Nouscom, a clinical stage immuno-oncology company developing off-the-shelf and personalized viral vector-based cancer vaccines targeting neoantigens, has announced the completion of its oversubscribed Series C equity financing raising €67.5 million ($72 million) from a syndicate of renowned
CONVOTIS has acquisted JMC Group and is entering the Swiss IT market as a platform company and strengthening its position in the managed services and digital platform solutions segment. This acquisition not only provides an
Private investment company Drs Investment sells 100 per cent of the shares in the Swiss software company Xelog to Prologistik Holding. The acquisition of Xelog, the Swiss logistics software specialist, is part of Prologistik’s strategy
The Private Equity firm Naxicap Germany (“Naxicap”) has acquired the Swiss company myStromer (“myStromer”). The sellers include the company’s founder and Swiss family offices. The parties have agreed not to disclose the details of
Walder Wyss advises Boehringer Ingelheim. The team was led by Alexander Gutmans (Partner, Corporate/M&A and Venture Capital - pictured left) and Robert von Rosen (Partner, Corporate/M&A and Venture Capital). VISCHER advised
